1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma
(
- Contribution to journal › Article
- 2017
-
Mark
Cancer risks and survival in patients with multiple primary melanomas : Association with family history of melanoma and germline CDKN2A mutation status
(
- Contribution to journal › Article
- 2016
-
Mark
Germline CDKN2A Mutation Status and Survival in Familial Melanoma Cases
(
- Contribution to journal › Article
-
Mark
Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations
(
- Contribution to journal › Article
- 2015
-
Mark
CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies.
(
- Contribution to journal › Article
- 2014
-
Mark
High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families.
(
- Contribution to journal › Article
-
Mark
Investigation of a putative melanoma susceptibility locus at chromosome 3q29.
(
- Contribution to journal › Article
- 2013
-
Mark
A variant in FTO shows association with melanoma risk not due to BMI
(
- Contribution to journal › Article
- 2011
-
Mark
Genome-wide association study identifies three new melanoma susceptibility loci
(
- Contribution to journal › Article
- 2009
-
Mark
MC1R variation and melanoma risk in the Swedish population in relation to clinical and pathological parameters
(
- Contribution to journal › Article